|
|
Volumn 51, Issue 3, 2008, Pages 320-327
|
|
Highlights of the 2007 Scientific Meeting of the Heart Failure Society of America. Washington, DC, September 16-19, 2007
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTINEOPLASTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ERYTHROPOIETIN;
HYDRALAZINE;
IRON;
LISINOPRIL;
PLACEBO;
SPIRONOLACTONE;
TOLVAPTAN;
WARFARIN;
ANEMIA;
CARDIOTOXICITY;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DEFIBRILLATOR;
DISEASE SEVERITY;
DOSE RESPONSE;
ECHOCARDIOGRAPHY;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HUMAN;
MEDICAL SOCIETY;
MITRAL VALVE REGURGITATION;
MONOTHERAPY;
PATIENT CARE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REVIEW;
UNITED STATES;
UNSPECIFIED SIDE EFFECT;
BENZAZEPINES;
BIOMEDICAL RESEARCH;
CARDIAC PACING, ARTIFICIAL;
FEMALE;
HEART FAILURE;
HUMANS;
MALE;
PRACTICE GUIDELINES AS TOPIC;
RECEPTORS, VASOPRESSIN;
SEX FACTORS;
STEM CELL TRANSPLANTATION;
TELEMEDICINE;
|
|
EID: 38149097872
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jacc.2007.11.026 Document Type: Review |
|
Times cited : (6)
|
|
References (1)
|
